FWM
CALA

Focused Wealth Management’s Calithera Biosciences, Inc CALA Stock Holding History

Focused Wealth Management’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25
Closed -$1K – 1144
2021
Q3 		$1K Hold
25
– – ﹤0.01% 976
2021
Q2 		$1K Hold
25
– – ﹤0.01% 914
2021
Q1 		$1K Buy
+25
New +$1.46K ﹤0.01% 896

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Focused Wealth Management's CALA Position: Q4 2021 in Review

Focused Wealth Management sold out of Calithera Biosciences, Inc (CALA) in Q4 2021, closing a stake of 25 shares — an estimated $1K sold.

Focused Wealth Management first reported a position in CALA in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 55 funds tracked by Wall St. Rank hold CALA as of Q4 2021.

  • Focused Wealth Management reported no remaining Calithera Biosciences, Inc position as of Q4 2021 after selling out during the quarter.
  • Focused Wealth Management sold 25 Calithera Biosciences, Inc shares in Q4 2021, an estimated $1K.
  • Focused Wealth Management first reported a position in Calithera Biosciences, Inc in Q1 2021 and held it in 3 quarters.
  • Focused Wealth Management's Calithera Biosciences, Inc position peaked at $1K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2021.

Based on Focused Wealth Management's 13F filing for Q4 2021, filed 31 Jan 2022.